Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 1:2020:7626274.
doi: 10.1155/2020/7626274. eCollection 2020.

The Effect of Different Treatment Regimens and Multiple Risk Factors on Adverse Pregnancy Outcomes among Syphilis-Seropositive Women in Guangzhou: A Retrospective Cohort Study

Fang Hu  1 , Shuai-Jun Guo  2   3 , Jian-Jun Lu  4   5 , Sui Zhu  6 , Ning-Xuan Hua  1 , Yan-Yan Song  1 , Jing-Jing Liang  1 , Jia Yu  7 , Sui-Fang Lin  1
Affiliations

The Effect of Different Treatment Regimens and Multiple Risk Factors on Adverse Pregnancy Outcomes among Syphilis-Seropositive Women in Guangzhou: A Retrospective Cohort Study

Fang Hu et al. Biomed Res Int. .

Abstract

Background: To eliminate mother-to-child transmission of syphilis, the Chinese government recommends a treatment regimen that slightly differs from the World Health Organization- (WHO-) recommended treatment. However, little is known about their difference in efficacy. This study is aimed at comparing the effect of China-recommended and WHO-recommend treatment regimens on adverse pregnancy outcomes (APOs) and at examining associated risk factors of APOs among syphilis-seropositive women.

Methods: Using the syphilis registry data, we retrospectively collected data from 4488 syphilis-infected pregnant women in Guangzhou during 2011-2018. Multivariate analyses were used to investigate the association between treatment regimens and APOs (ectopic pregnancy, spontaneous abortion, stillbirth, preterm birth or low birth weight, newborn smaller than gestational age, congenital syphilis, and infant death) and the association between risk factors and APOs.

Results: Of 3474 participants, 27.3% had at least one APO. Compared to those receiving WHO-recommended treatment, women who received China-recommended treatment were less likely to have APOs (odds ratio (OR) 0.47, 95% confidence interval (CI) 0.38-0.57), whereas those who received no treatment had 1.6 times higher odds of experiencing APOs. One common risk factor across different APOs was high levels of log2-transformed toluidine red unheated serum test (TRUST) titers before treatment (OR 1.14, 95% CI 1.10-1.19). China-recommended treatment was effective in reducing APOs for those with TRUST ≥ 1 : 8 (OR 0.21, 95% CI 0.14-0.29) and those with TRUST < 1 : 8 (OR 0.62, 95% CI 0.50-0.77).

Conclusions: Syphilis-seropositive women receiving China-recommended treatment had lower odds of APOs, especially when TRUST titers before treatment were high. Findings can be used to guide health professionals to reduce APOs among syphilis-infected mothers and promote nationwide use of China-recommended treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Sample size flow chart for the study analysis. CS: congenital syphilis; SGA: small for gestational age.
Figure 2
Figure 2
Curve estimation for proportions of adverse pregnancy outcomes in women with syphilis. TRUST: toluidine red unheated serum test.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. World Health Organization. The global elimination of congenital syphilis: rationale and strategy for action. 2007. August 2016, https://apps.who.int/iris/bitstream/10665/43782/1/9789241595858_eng.pdf.
    1. Korenromp E. L., Rowley J., Alonso M., et al. Global burden of maternal and congenital syphilis and associated adverse birth outcomes-estimates for 2016 and progress since 2012. PLoS One. 2019;14(2, article e0211720) doi: 10.1371/journal.pone.0211720. - DOI - PMC - PubMed
    1. Trivedi S., Williams C., Torrone E., Kidd S. National trends and reported risk factors among pregnant women with syphilis in the United States, 2012-2016. Obstetrics and Gynecology. 2019;133(1):27–32. doi: 10.1097/AOG.0000000000003000. - DOI - PMC - PubMed
    1. Hong F. C., Wu X. B., Yang F., et al. Risk of congenital syphilis (CS) following treatment of maternal syphilis: results of a CS control program in China. Clinical Infectious Diseases. 2017;65(4):588–594. doi: 10.1093/cid/cix371. - DOI - PubMed
    1. Taylor M. M., Zhang X., Nurse-Findlay S., Hedman L., Kiarie J. The amount of penicillin needed to prevent mother-to-child transmission of syphilis. Bulletin of the World Health Organization. 2016;94(8):559–559A. doi: 10.2471/BLT.16.173310. - DOI - PMC - PubMed